Global Sleeping Aids Market is estimated to reach $96 billion by 2024, Says Variant Market Research

1
Global Sleeping Aids Market is estimated to reach
96 billion by 2024, Says Variant Market Research

• Bhavana Patel
• SEO Analyst
• help_at_variantmarketresearch.com

2
Sleeping Aids Market

• Global Sleeping Aids Market is estimated to reach
  96 billion by 2024 growing at a CAGR of 6.3
  from 2016 to 2024. Sleeping aids are medicines,
  which are used to diagnose and treat various
  sleeping disorders. Symptoms of sleep disorder
  are daytime sleepiness, sleep apnea, insomnia.
  These sleep disorders adversely affect human
  health which can lead to number of chronic
  diseases, such as diabetes, high blood pressure,
  arthritis, obesity, and stroke. To avoid major
  adverse effects on body, it is important to treat
  and diagnose these sleep disorders.
• Browse the Complete Report _at_ https//www.variantma
  rketresearch.com/report-categories/pharmaceuticals
  /sleeping-aids-market

3
Sleeping Aids Market Size and forecast, 2015 -
2024
4
Sleeping Aids Market

• The global sleeping aids market is segmented on
  basis of product and sleep disorder. The sleeping
  aids market is segmented by product as mattresses
  and pillows, sleep laboratories, medication
  (prescription based drugs, herbal drugs, OTC
  drugs), sleep apnea devices and others. Further,
  the market is segmented by sleep disorder as
  insomnia, sleep apnea, restless legs syndrome,
  narcolepsy, sleep walking, and other sleep
  disorders.
• Get Sample Report _at_ https//www.variantmarketresea
  rch.com/report-categories/pharmaceuticals/sleeping
  -aids-market/sample-request

5
Sleeping Aids Market Share by Region, 2024
6
Top Key Players

• Takeda Pharmaceutical Company Limited
• CareFusion Corporation
• Pfizer
• Teva Pharmaceutical Industries Limited
• Natus Medical Incorporated
• Compumedics Limited
• Merck And Co.
• Sanofi
• GlaxoSmithKline Plc., and Serta International,
  among others.

7
The key takeaways from the report

• The report will provide detailed analysis of
  Global Sleeping Aids Market with respect to major
  segments such as product and sleep disorder
• The report will include the qualitative and
  quantitative analysis with market estimation over
  2015-2024 and compound annual growth rate (CAGR)
  between 2016 and 2024
• Comprehensive analysis of market dynamics
  including factors and opportunities will be
  provided in the report
• An exhaustive regional analysis of Global
  Sleeping Aids Market has been included in the
  report
• Profile of the key players in the Global Sleeping
  Aids Market, will be provided, which include key
  financials, product services, new developments
  and business strategies

8
Scope of Global Sleeping Aids Market  

• Product Segments
• Mattresses and Pillows
• Sleep Laboratories
• Medication
• Prescription Based Drugs
• Herbal Drugs
• OTC drugs
• Sleep Apnea Devices
• Other Products

9
Scope of Global Sleeping Aids Market  

• Sleep disorder Segments
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders

10
Scope of Global Sleeping Aids Market  

• Geographical Segments
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Others

11
Scope of Global Sleeping Aids Market  

• Geographical Segments
• Asia-Pacific
• India
• China
• Japan
• South Korea
• Others
• RoW
• South America
• Middle East
• Africa

12
Table of content

• Chapter 1 Prefix
• 1.1 Market Scope
• 1.2 Report Description
• 1.3 Research Methodology
• 1.3.1 Primary Research
• 1.3.2 Secondary Research
• 1.3.3 In-house Data Modeling
• Chapter 2 Executive Summary

13
Table of content

• Chapter 3 Market Outline
• 3.1 Market Inclination, Trend, Outlook and
  Viewpoint
• 3.2 Market Share Analysis Companys
  Competitive Scenario
• 3.3 Market Dynamics
• 3.3.1 Drivers
• 3.3.1.1 Impact Analysis
• 3.3.2 Restraints
• 3.3.2.1 Impact Analysis
• 3.3.3 Opportunities

14
Table of content

• Chapter 7 Company Profiles
• 7.1 Takeda Pharmaceutical Company Limited
• 7.2 CareFusion Corporation
• 7.3 Pfizer
• 7.4 Teva Pharmaceutical Industries Limited
• 7.5 Natus Medical Incorporated
• 7.6 Compumedics Limited
• 7.7 Merck And Co.
• 7.8 Sanofi
• 7.9 GlaxoSmithKline Plc
• 7.10 Serta International

15
Contact us

• Michael Mendes
• Head - Sales
• Variant Market Research
• 649 Mission St, 5th Floor, San Francisco, CA
  94105, United States.
• Tel [phone]
• Fax [phone]
• Email michael.mendes_at_variantmarketresearch.com
• Email help_at_variantmarketresearch.com

16
Thank you

• Follow Us..

Variant Market Research
variant-market-research
_at_vmrreports
variantmarketresearch